All eyes on the inflation data
Marketplace All-in-One
00:00
Biotech Shift: China and the U.S. Race
This chapter analyzes the rise of China's biotechnology sector and its impact on U.S. pharmaceutical firms, particularly in drug rights acquisition and blood cancer treatments like BTK inhibitors. It highlights the strategic implications for U.S. investments and regulatory approaches in response to China's growing prominence in pharmaceutical innovation.
Transcript
Play full episode
